101878381-钢都游子
Set a live reminder
Here's your $NVIDIA(NVDA.US$ exclusive - NVDA is now the second most valuable company in the world, overtaking Apple. How can you potentially utilize the opportunities surrounding Nvidia's 10-to-1 stock split? Come join in this interactive session and learn possible tools you can use to take charge of with our Vice President of Strategy from Moomoo Technologies, Justin Zacks ( @Justin Zacks). Olivia Higgins ( @olivehiggo) wil...
![](https://usliveimg.moomoo.com/20240608225545e492c7e.png/thumb)
28
1
101878381-钢都游子
voted
Morning mooers! Happy Monday, and happy June! The market is open, memeing and mixed, and T+1 settlement might still cause issues. Shortly after 10 AM the New York Stock Exchange showed pricing errors, displaying $Berkshire Hathaway-B (BRK.B.US)$down 99%.
UPDATE 11:40: the stock resumed trade just past 11:30 AM, up about 1%.
It wasn't the only equity haulted on the way down from pricing errors, as $Chipotle Mexican Grill (CMG.US)$ an about ...
UPDATE 11:40: the stock resumed trade just past 11:30 AM, up about 1%.
It wasn't the only equity haulted on the way down from pricing errors, as $Chipotle Mexican Grill (CMG.US)$ an about ...
![Berkshire -99%, Flat Market, and Gamestop Memes | Herd on Wall Street](https://1500015405.vod2.myqcloud.com/f7703b98vodtransuse1500015405/6beae1de1253642698252042552/coverBySnapshot/coverBySnapshot_10_0.jpg)
52
11
101878381-钢都游子
liked
$Bristol-Myers Squibb(BMY.US$ 🔔
FDA Approves Breyanzi as New CAR T Cell Therapy
for Relapsed or Refractory Mantle Cell Lymphoma
⇨ only CAR T cell therapy approved for 4 distinct subtypes of non-Hodgkin lymphoma 🩸
⇨ TRANSCEND NHL 001 trial (MCL cohort) 🧫
» delivered responses in 85.3% of patients with one-time infusion
FDA Approves Breyanzi as New CAR T Cell Therapy
for Relapsed or Refractory Mantle Cell Lymphoma
⇨ only CAR T cell therapy approved for 4 distinct subtypes of non-Hodgkin lymphoma 🩸
⇨ TRANSCEND NHL 001 trial (MCL cohort) 🧫
» delivered responses in 85.3% of patients with one-time infusion
![Picture](https://ussnsimg.moomoo.com/sns_client_feed/70042970/20240531/3d9913179dc2472eaf137d90b02a43e6.jpg/thumb?area=100&is_public=true)
![Picture](https://ussnsimg.moomoo.com/sns_client_feed/70042970/20240531/fd5be1d0e8214690b1cc879f1cbd4e34.jpg/thumb?area=100&is_public=true)
6
101878381-钢都游子
liked
» Holdings: 75
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S(ASND.US$
$Vaxcyte(PCVX.US$
$Legend Biotech(LEGN.US$
$Janux Therapeutics(JANX.US$
$Aerovate(AVTE.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Evolent Health(EVH.US$
$NewAmsterdam Pharma(NAMS.US$
$RxSight(RXST.US$
$TYRA BIOSCIENCES, INC.(TYRA.US$
$Edgewise Therapeutics(EWTX.US$
$4D Molecular Therapeutics(FDMT.US$
$Biogen(BIIB.US$
$PepGen(PEPG.US$
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S(ASND.US$
$Vaxcyte(PCVX.US$
$Legend Biotech(LEGN.US$
$Janux Therapeutics(JANX.US$
$Aerovate(AVTE.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Evolent Health(EVH.US$
$NewAmsterdam Pharma(NAMS.US$
$RxSight(RXST.US$
$TYRA BIOSCIENCES, INC.(TYRA.US$
$Edgewise Therapeutics(EWTX.US$
$4D Molecular Therapeutics(FDMT.US$
$Biogen(BIIB.US$
$PepGen(PEPG.US$